Dental Times

clinical

Akelos receives NIH grant to continue research on nonopioid alternative for neuropathic pain

The therapy would be based on a molecule that selectively blocks an ion channel protein that can become overactive in peripheral neuropathic pain.

By ADA News ·

The therapy would be based on a molecule that selectively blocks an ion channel protein that can become overactive in peripheral neuropathic pain.

Read the original reporting at ADA News